Xiaoxia Chu
Qingdao University(CN)Tongji University(CN)Yuhuangding Hospital(CN)Shanghai Pulmonary Hospital(CN)
Publications by Year
Research Areas
Chronic Lymphocytic Leukemia Research, Multiple Myeloma Research and Treatments, Lymphoma Diagnosis and Treatment, Platelet Disorders and Treatments, Protein Degradation and Inhibitors
Most-Cited Works
- → Cell‐mediated lysis of autologous platelets in chronic idiopathic thrombocytopenic purpura(2006)163 cited
- → A multicenter randomized open-label study of rituximab plus rhTPO vs rituximab in corticosteroid-resistant or relapsed ITP(2015)111 cited
- → Correction of Th1-dominant Cytokine Profiles by High-dose Dexamethasone in Patients with Chronic Idiopathic Thrombocytopenic Purpura(2007)96 cited
- → High‐dose dexamethasone plus recombinant human thrombopoietin vs high‐dose dexamethasone alone as frontline treatment for newly diagnosed adult primary immune thrombocytopenia: A prospective, multicenter, randomized trial(2020)59 cited
- → A prospective, multicenter study of low dose decitabine in adult patients with refractory immune thrombocytopenia(2019)48 cited
- → A novel dominant-negative PD-1 armored anti-CD19 CAR T cell is safe and effective against refractory/relapsed B cell lymphoma